Search all trials

Find therapies in clinical trials near you – page 13

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Pulmonary arterial hypertension

Not recruiting

Investigational

Study on the Safety and Effects of PF-07868489 in Patients with Pulmonary Arterial Hypertension

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:PF-07868489

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:TALADEGIB

Contact Research Centre

Mucopolysaccharidosis II

Not recruiting

Registered drugNo placebo

Study on the Effects and Safety of JR-141 and Idursulfase for Patients with Hunter Syndrome

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Idursulfase

Contact Research Centre

Pulmonary fibrosis

Not recruiting

Investigational

Study on the Effects of Inhaled Treprostinil for Patients with Progressive Pulmonary Fibrosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Treprostinil

Contact Research Centre

Study on Higher Doses of Nusinersen for Patients with Spinal Muscular Atrophy Who Previously Participated in a Nusinersen Study

Not recruiting

InvestigationalNo placebo

Study on Higher Doses of Nusinersen for Patients with Spinal Muscular Atrophy Who Previously Participated in a Nusinersen Study

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Nusinersen

Contact Research Centre

Pulmonary hypertension

Not recruiting

Investigational

Study on the Effects of Mosliciguat for Patients with Pulmonary Hypertension Linked to Interstitial Lung Disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Mosliciguat

Contact Research Centre

Primary progressive multiple sclerosis

Not recruiting

Investigational

Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

Investigational

Germany

Participants:18–64 years
Substances:Tolebrutinib

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Registered drug

Study on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Registered drug

Germany

Participants:18–64 years
Substances:Fenebrutinib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

InvestigationalNo placebo

Study Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Amivantamab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Gilteritinib

Contact Research Centre

Find therapies in clinical trials near you – page 13

244 trials match your criteria

Pulmonary arterial hypertension

Study on the Safety and Effects of PF-07868489 in Patients with Pulmonary Arterial Hypertension

Idiopathic pulmonary fibrosis

Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

Mucopolysaccharidosis II

Study on the Effects and Safety of JR-141 and Idursulfase for Patients with Hunter Syndrome

Pulmonary fibrosis

Study on the Effects of Inhaled Treprostinil for Patients with Progressive Pulmonary Fibrosis

Study on Higher Doses of Nusinersen for Patients with Spinal Muscular Atrophy Who Previously Participated in a Nusinersen Study

Study on Higher Doses of Nusinersen for Patients with Spinal Muscular Atrophy Who Previously Participated in a Nusinersen Study

Pulmonary hypertension

Study on the Effects of Mosliciguat for Patients with Pulmonary Hypertension Linked to Interstitial Lung Disease

Primary progressive multiple sclerosis

Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

Relapsing multiple sclerosis

Study on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Non-small cell lung cancer

Study Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer

Non-small cell lung cancer

Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Plasma cell myeloma

Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Acute myeloid leukaemia+1

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.